Endocrinology (all articles)
RCT | Safety and efficacy of Liraglutide vs. Colesevelam for treating bile acid diarrhea.
26 Jul, 2022 | 12:29h | UTCSafety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)
Commentary: Diabetes Drug for Bile Acid Diarrhea Bests Standard of Care in Small Trial — Liraglutide proves superior to colesevelam for cutting daily stool frequency in Danish trial – MedPage Today (free registration required)
Commentary on Twitter
New research – Kårhus et al – Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trialhttps://t.co/7Q69CcvjcJ#BAD #GITwitter @MKarhus @filip_Knop pic.twitter.com/lkfSLLgokO
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) July 20, 2022
RCT | Effect of canagliflozin on the decline of estimated glomerular filtration rate in chronic kidney disease patients with type 2 diabetes mellitus.
26 Jul, 2022 | 11:53h | UTC
M-A | TSH and FT4 reference intervals in pregnancy.
25 Jul, 2022 | 12:56h | UTC
Chasing LDL cholesterol to the bottom — PCSK9 in perspective.
22 Jul, 2022 | 11:36h | UTCChasing LDL cholesterol to the bottom — PCSK9 in perspective – Nature Cardiovascular Research (if the link is paywalled, try this one)
Commentary on Twitter
Review| @LaleTokgozoglu and Peter Libby discuss the management of #atherogenic #LDL cholesterol with an emphasis on the role #PCSK9 inhibition strategies https://t.co/k1wPKAdotU
— Nature Cardiovascular Research (@NatureCVR) June 17, 2022
An approach to the management of diabetes mellitus in cirrhosis: a primer for the hepatologist.
22 Jul, 2022 | 11:26h | UTC
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases.
21 Jul, 2022 | 13:11h | UTC
Open-label RCT | Moderate-intensity statin plus ezetimibe is noninferior to high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease.
20 Jul, 2022 | 12:32h | UTCLong-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial – The Lancet (link to abstract – $ for full-text)
RCT | Efficacy and safety of once-weekly Efpeglenatide monotherapy versus placebo in Type 2 Diabetes.
19 Jul, 2022 | 13:20h | UTC
Review | Cardiometabolic comorbidities in cancer survivors.
19 Jul, 2022 | 13:17h | UTCCardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolemia.
18 Jul, 2022 | 11:18h | UTC
Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988).
18 Jul, 2022 | 11:09h | UTC
Cohort Study | Association of polycystic ovary syndrome with offspring morbidity.
18 Jul, 2022 | 10:58h | UTCAssociation of PCOS with offspring morbidity: a longitudinal cohort study – Human Endocrinology
Burden of diabetes and hyperglycemia in adults in the Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.
18 Jul, 2022 | 10:54h | UTC
Cohort Study | Risks of stroke and heart disease following hysterectomy and oophorectomy in premenopausal women.
15 Jul, 2022 | 13:07h | UTCCommentary: Removal of Uterus, Ovaries Poses Extra Cardiovascular Risk for Younger Women – MedPage Today (free registration required)
Guideline on prevention of foot ulceration in diabetic patients.
15 Jul, 2022 | 12:51h | UTCRelated:
Guideline: ADA 2022 Standards of Medical Care in Diabetes.
NICE Updated Guidance: Management of Type 2 Diabetes.
Recent updates to clinical practice guidelines for diabetes mellitus.
Nutrition and lifestyle recommendations for patients with gout and hyperuricemia.
13 Jul, 2022 | 11:37h | UTC
M-A | Dual-hormone artificial pancreas for glucose control in type 1 diabetes.
13 Jul, 2022 | 11:19h | UTC
ADA Guideline Summary | Obesity and weight management for prevention and treatment of Type 2 Diabetes.
12 Jul, 2022 | 13:06h | UTCObesity and Weight Management for Prevention and Treatment of Type 2 Diabetes – JAMA (free for a limited period)
Original Guideline: ADA 2022 Standards of Medical Care in Diabetes – American Diabetes Association
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient.
12 Jul, 2022 | 12:48h | UTCCommentary: National Lipid Association Scientific Statement on Statin Intolerance – American College of Cardiology
Study finds childhood obesity occurring at greater frequency, with more severity and at younger ages.
11 Jul, 2022 | 12:10h | UTCNews Release: Study finds childhood obesity occurring at greater frequency, with more severity and at younger ages – Emory University
Original Study: Changes in the Incidence of Childhood Obesity – Pediatrics
M-A | Antithyroid drug therapy in pregnancy and risk of congenital anomalies.
8 Jul, 2022 | 11:36h | UTC
M-A | Endocrine-disrupting chemicals and the risk of gestational diabetes mellitus.
8 Jul, 2022 | 11:25h | UTC
Post-hoc analysis | Can SGLT2 inhibitors reduce the risk of nephrolithiasis?
7 Jul, 2022 | 12:42h | UTC
Post-hoc analysis | Can SGLT2 inhibitors reduce the risk of hyperuricemia and gout?
7 Jul, 2022 | 12:40h | UTC
Guideline on the diagnosis and management of peripheral artery disease.
6 Jul, 2022 | 11:42h | UTCRelated: